- Table of Contents
We validate the specificity of these antibodies to Angiotensinogen by testing them on tissues known to express AGT positively and negatively. Browse below to find the AGT antibody that suites your experiment. We have 9 of these antibodies and many publications and validation images.
If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.
Facts about Angiotensinogen.
AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8); angiotensin I; angiotensin II; ANHU; SERPINA8
|Sequence:||1; NC_000001.11 (230702523..230714122, complement)|
Expressed by the liver and secreted in plasma.
Boster Bio is an excellent option if you are looking for a new anti-bodivirus. These antibodies have been validated across multiple platforms and include negative and positive samples. Furthermore, Boster's validation process ensures high specificity and affinity. Boster is also a generous rewarder, rewarding scientists who review their products for the first time. That's the reason it has received glowing reviews from scientists across the world.
Bioz, a proprietary technology that integrates NLP and Machine Learning, gives researchers access to real-world applications of scientific papers. Boster Bio uses this technology to display the most current citations of relevant products. Boster's products are currently cited in more than 29,000 scientific research papers. This confirms the high-quality Boster's product and increases the trust of researchers.
For biomarkers in development, rigorous validation is vital to demonstrating their value and allowing clinical use. Unfortunately, high-quality specimens are expensive and in limited availability. The Early Detection Research Network has created valuable reference sets of specimens which can be utilized by several biomarker validation labs, thereby maximizing the use of specimens and increasing the efficiency of biomarker validation. These reference sets permit biomarker candidates to be evaluated in a sequential manner, not simultaneously which allows for faster, more efficient validation.
*More publications can be found for each product on its corresponding product page